CAD risk alleles were all associated with reduced ANRIL expression, up to 1.9-fold, suggesting that expression of ANRIL, rather than CDKN2A or CDKN2B, might mediate atherosclerosis susceptibility. This evidence concerns the gene CDKN2A and atherosclerosis.